ArticleJournal of Cancer2019

Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: Current Status, Resistance, and Combination Strategies.

Ying Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.